wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39192955-A70DCEEE-C160-4505-A717-526FC4D6933E
Q39192955-A70DCEEE-C160-4505-A717-526FC4D6933E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39192955-A70DCEEE-C160-4505-A717-526FC4D6933E
Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer.
P2860
Q39192955-A70DCEEE-C160-4505-A717-526FC4D6933E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39192955-A70DCEEE-C160-4505-A717-526FC4D6933E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a7c538b1954a7e995f6b333eb42376d0174e7f07
P2860
A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure.